We are excited to share the first public update on MoyoGuard, a working prototype portable ECG screening device developed at the Muhimbili University of Health and Allied Sciences (MUHAS).
Our Vision
Cardiovascular disease remains a leading cause of morbidity worldwide. MoyoGuard aims to bring reliable, point-of-care ECG screening to communities where access to specialist cardiac diagnostics is limited.
What Makes MoyoGuard Different
- Portable design — compact enough for field use and clinic workflows
- AI-assisted analysis — on-device and cloud-assisted rhythm interpretation
- Built for collaboration — open to research partnerships and institutional pilots
What's Next
We are actively seeking research collaborators and pilot institutions. If your organization is interested in evaluating MoyoGuard, visit our Pilot Program or Research Collaboration pages.
Stay tuned for more updates as we progress through validation and field testing.